We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$41.1M
2
ADBE icon
Adobe
ADBE
+$23M
3
NSC icon
Norfolk Southern
NSC
+$13.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.6M
5
OTIS icon
Otis Worldwide
OTIS
+$6.73M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RF icon
926
Regions Financial
RF
$26.3B
$1.78K ﹤0.01%
100
– –
URI icon
927
United Rentals
URI
$71.1B
$1.78K ﹤0.01%
4
– –
EDIT icon
928
Editas Medicine
EDIT
$399M
$1.73K ﹤0.01%
210
– –
CHMG icon
929
Chemung Financial Corp
CHMG
$390M
$1.65K ﹤0.01%
43
– –
VXF icon
930
Vanguard Extended Market ETF
VXF
$30.3B
$1.64K ﹤0.01%
+11
New +$1.54K
AGNT
931
AGNT Inc
AGNT
$664M
$1.62K ﹤0.01%
+80
New +$1.2K
FIVE icon
932
Five Below
FIVE
$11.2B
$1.57K ﹤0.01%
8
– –
ADNT icon
933
Adient
ADNT
$1.6B
$1.57K ﹤0.01%
41
+20
+95% +$739
MUFG icon
934
Mitsubishi UFJ Financial
MUFG
$258B
$1.57K ﹤0.01%
213
– –
VOD icon
935
Vodafone
VOD
$34.9B
$1.54K ﹤0.01%
163
-343
-68% -$3.6K
LEN icon
936
Lennar Class A
LEN
$20.4B
$1.5K ﹤0.01%
12
– –
CROX icon
937
Crocs
CROX
$6.69B
$1.46K ﹤0.01%
13
– –
LEG icon
938
Leggett & Platt
LEG
$1.52B
$1.42K ﹤0.01%
48
– –
KRG icon
939
Kite Realty
KRG
$5.95B
$1.39K ﹤0.01%
+62
New +$1.28K
AFRM icon
940
Affirm
AFRM
$23.5B
$1.29K ﹤0.01%
84
– –
FLNA
941
Filana Therapeutics
FLNA
$43M
$1.23K ﹤0.01%
50
– –
BATT icon
942
Amplify Lithium & Battery Technology ETF
BATT
$113M
$1.18K ﹤0.01%
90
+50
+125% +$629
GAP
943
The Gap Inc
GAP
$6.84B
$1.12K ﹤0.01%
125
– –
GERN icon
944
Geron
GERN
$911M
$1.09K ﹤0.01%
340
– –
PDD icon
945
Pinduoduo
PDD
$118B
$968 ﹤0.01%
14
– –
DXC icon
946
DXC Technology
DXC
$1.63B
$856 ﹤0.01%
32
-619
-95% -$15.4K
SOFI icon
947
SoFi Technologies
SOFI
$21.1B
$834 ﹤0.01%
100
– –
BFH icon
948
Bread Financial
BFH
$4.21B
$817 ﹤0.01%
26
– –
FL
949
DELISTED
Foot Locker
FL
$814 ﹤0.01%
+30
New +$1.02K
AKLI
950
DELISTED
Akili Inc
AKLI
$794 ﹤0.01%
715
– –
36 37
38
39 40

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.